Table 1 Comparison of baseline characteristics between oxycodone hydrochloride group and flurbiprofen axidate group.

From: Comparison of oxycodone hydrochloride and flurbiprofen axetil on analgesia in mechanically ventilated patients with respiratory failure in a multicenter study

Factors

Oxycodone hydrochloride group

N = 207

Flurbiprofen axetil group

N = 207

P

Gender (n, %)

0.843

 Male

93 (44.9%)

91 (44.0%)

 

 Female

114 (55.1%)

116 (56.0%)

 

Age (year)

58 ± 15

57 ± 16

0.972

Hypertension (n, %)

0.227

 Yes

75 (36.2%)

87 (42.0%)

 

 No

132 (63.8%)

120 (58.0%)

 

Coronary heart disease (n, %)

0.654

 Yes

24 (11.6%)

27 (13.0%)

 

 No

183 (88.4%)

180 (87.0%)

 

Diabetes (n, %)

0.901

 Yes

41 (19.8%)

40 (19.3%)

 

 No

166 (80.2%)

167 (80.7%)

 

Shock (n, %)

0.842

 Yes

89 (43.0%)

87 (42.0%)

 

 No

118 (57.0%)

120 (58.0%)

 

AKI (n, %)

0.128

 Yes

80 (38.6%)

78 (37.7%)

 

 No

127 (61.4%)

129 (62.3%)

 

APACHE II (median)

12 (9–16)

11 (8–16)

0.339

SOFA (median)

5 (3–8)

5 (3–8)

0.818

  1. AKI acute kidney injury, APCHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment.